cGAS-STING pathway targeted therapies and their applications in the treatment of high-grade glioma

Keyphrases

• Stimulator of Interferon Genes (STING) 100%
• High-grade Glioma 100%
• Cyclic GMP-AMP Synthase (cGAS) 100%
• Pathway-targeted Therapy 100%
• Stimulator of Interferon Genes Pathway 100%
• Interferon-α (IFN-α) 50%
• Tumor 50%
• Antigen Presentation 50%
• Immune Response 50%
• Myeloid Cells 50%
• Adjuvant Temozolomide 50%
• Glioblastoma 50%
• Standard of Care 50%
• Contrast Enhancement 50%
• Radiation Therapy 50%
• Therapeutic Approaches 50%
• Glioma 50%
• Tumor Microenvironment 50%
• Patient Survival 50%
• Median Survival 50%
• Potential Biomarkers 50%
• Combinational Therapy 50%
• Immunosuppressive Myeloid Cells 50%
• T Cell Infiltration 50%
• Effector T Cells 50%
• Gene Response 50%
• Maximal Safe Resection 50%
• Stimulator of Interferon Genes Agonist 50%
• Immune-suppressive 50%

Medicine and Dentistry

• Interferon 100%
• Targeted Therapy 100%
• Ganglioglioma 100%
• Myeloid Cell 40%
• Biological Marker 20%
• Neoplasm 20%
• Immune Response 20%
• Cellular Infiltration 20%
• T Cell 20%
• Glioblastoma 20%
• Temozolomide 20%
• Tumor Microenvironment 20%
• Antigen Presentation 20%
• Radiation Therapy 20%